For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on June 26th, 2025 | 07:35 CEST
Sensational news drives shares: RENK, BYD, and Desert Gold
A major announcement from Desert Gold: the gold explorer has secured another exciting project. In an interview, the CEO expressed strong optimism. The new asset offers synergies with the Company's existing mega-project, which is nearing a PEA. The goal is to become a gold producer by 2026 - significantly increasing the likelihood of a takeover. RENK & Co. benefited yesterday from the NATO meeting and a cheerful Donald Trump. The confirmation of the 5% target for defense spending caused defense stocks to rise. In contrast, BYD shares remain weak. The Chinese are rushing from one sales record to another – or were they rushing? Because they seem to be falling victim to their own strategy. Investors are fleeing.
Read
Commented by Fabian Lorenz on June 25th, 2025 | 07:30 CEST
BioNTech swallows CureVac! Evotec and Vidac Pharma next? Price driver takeover and Buy recommendation
Is Vidac Pharma about to see another price explosion? Last fall, the share rose by around 200%. Yesterday, there was a "Buy" recommendation. Analysts see potential for growth in this biotech gem. The latest news on the drug candidate VDA 1102 for brain tumors is promising. Could a takeover be on the cards? CureVac's share price has nearly doubled since the beginning of April. BioNTech plans to acquire its mRNA competitor and thus end patent disputes. Evotec is a permanent fixture on the takeover merry-go-round. However, this currently seems to be the only hope for rising share prices. The management's new strategy has not created the hoped-for wave of optimism. Is it still worth buying now?
Read
Commented by Fabian Lorenz on June 24th, 2025 | 07:10 CEST
FOCUS online reports on miracle concrete: Argo Living Soils is working on a revolution in construction!
The construction industry is under enormous pressure: infrastructure is aging, the demand for new buildings is growing - and at the same time, CO₂ emissions must be reduced urgently. This presents opportunities for innovators to earn billions. Argo Living Soils is one such innovator. Nanomaterials are being used to create a miracle concrete which could revolutionize the construction industry. The potential has even been recognized by FOCUS Online, which recently reported on the project in detail. The article not only highlights the technological innovation surrounding graphene concrete but also emphasizes Argo's role as the driving force behind its development. The enormous potential relative to the valuation of EUR 10 million speaks in favor of buying the stock.
Read
Commented by Fabian Lorenz on June 23rd, 2025 | 07:10 CEST
DRONE STOCK: Volatus Aerospace benefits from NATO billions - and much more! BUY RECOMMENDATION!
The drone revolution has only just begun. In Ukraine, remote-controlled aircraft have become a game changer in modern warfare. Defense is just one of many industries being disrupted by drones equipped with the latest camera technology and AI. These all-rounders can transport goods to remote areas, inspect buildings and bridges for structural damage, and even act as aerial fire extinguishers during high-rise fires. One insider tip in this billion-dollar market is Volatus Aerospace. The Canadian company offers numerous services - from drone pilot training to surveillance - and generates recurring revenue streams. The latest capital increase was oversubscribed and should give the stock fresh momentum. Analysts forecast that revenues will soon exceed CAD 80 million and are issuing a "Buy" recommendation for the stock.
Read
Commented by Fabian Lorenz on June 20th, 2025 | 06:55 CEST
Declaration of war on the pharmaceutical industry? Bayer, Novo Nordisk, and insider tip PanGenomic Health
Has US Health Secretary Robert F. Kennedy Jr. declared war on the traditional pharmaceutical industry? That is certainly what former Trump press secretary and current podcaster Anthony Scaramucci seems to think. The reason for this is the complete overhaul of the US Vaccine Advisory Committee. One company set to benefit from the new US Health Secretary is PanGenomic Health. The Company plans to launch a new digital health and alternative medicine business this year. If it manages to secure even a small share of this billion-dollar market, its share price could multiply. The price target for Novo Nordisk was recently reduced. The stock is working on bottoming out, and there was a success for the blockbuster in the US. Bayer's stock is trending favorably. Regular positive news is currently overshadowing the legal disputes in the US. There was recently some positive news to report there.
Read
Commented by Fabian Lorenz on June 19th, 2025 | 07:05 CEST
Share price speculation thanks to drones and artificial intelligence: Rheinmetall, BioNTech, and NetraMark shares
Drones and artificial intelligence are set to revolutionize entire industries. Listed companies that play a leading role in this transformation hold significant upside potential, such as NetraMark. Using artificial intelligence, the Company helps pharmaceutical and biotech companies shorten development times and reduce costs. NetraMark also aims to help shape industry trends. BioNTech, too, relies on AI for its research, frequently acquiring specialized companies. Perhaps NetraMark will be next? In any case, the Canadians would still be a bargain. Rheinmetall shares, on the other hand, are certainly not cheap. However, the multibillion-euro defense budgets for rearmament in Europe are fueling speculation. In order to be able to deliver not only tanks, howitzers, and ammunition quickly, but also cutting-edge technology, Germany's largest defense contractor is focusing on partnerships. This is evident in its latest partnership, which is expected to enable Rheinmetall to deliver combat and kamikaze drones quickly.
Read
Commented by Fabian Lorenz on June 18th, 2025 | 07:00 CEST
Almonty Industries: Analysts raise target price! 75% Upside Potential! CEO clearly backs Rheinmetall and Co. on CNBC
Anything other than further price increases for Almonty shares in the coming weeks would be a surprise. The tungsten gem is facing a hot summer. The main driver for the share price will be the commissioning of the mega mine in South Korea. Due to the increasing visibility of revenue and profit growth, analysts have significantly raised their price targets for the share. With its unique market position, the Company remains attractively valued compared to its peers. With the planned upcoming NASDAQ listing, the stock is expected to attract greater attention from US investors. That Almonty is gaining more visibility is underscored by CEO Lewis Black's recent interview with CNBC. In it, Black emphasized that Almonty already supplies 85% of its production to the defense sector. Rheinmetall, for example, needs tungsten to harden ammunition.
Read
Commented by Fabian Lorenz on June 17th, 2025 | 07:30 CEST
BUY NOW!? Hensoldt, TUI, and Walmart partner MiMedia
Is the consolidation at Hensoldt already over? The sensor technology specialist's shares got off to a good start this week. The trade fair that began yesterday could provide momentum. Among other things, Hensoldt is showcasing radars used in Ukraine as part of the IRIS-T SLM air defense system. Analysts certainly see upside potential. MiMedia shares are also exciting. Chart-wise, the Walmart partner's stock appears to be on the verge of a breakout. The cloud insider tip's previously announced partnerships should start bearing fruit in the second half of the year. In contrast, TUI shares are currently facing some headwinds. The conflict in the Middle East is weighing on the aviation and tourism industry, and there is a dispute with Airbnb over overtourism.
Read
Commented by Fabian Lorenz on June 17th, 2025 | 07:15 CEST
More than 50% upside potential with European tech! SAP, Zalando, Ionos, and naoo shares
There is a spirit of optimism in the European tech industry. The continent aims to become less dependent on the US, not only in terms of defense, but also in the technology sector. The tariff dispute and Microsoft's blocking of email access at the International Court of Justice are fueling a tech boom in Europe. SAP and Ionos are supporting Schwarz Digits in setting up a hyperscaler. Zalando shares are being recommended as a buy. And the chances for naoo AG to establish a European social network appear better than ever. The Swiss company's shares may be on the verge of a revaluation.
Read
Commented by Fabian Lorenz on June 16th, 2025 | 07:20 CEST
Alarm bells ringing for GOLD and DEFENSE: RENK, Barrick Mining, and comeback story AJN Resources
Is the gold price facing a short squeeze? The ECB is certainly painting a horror scenario. This could have serious consequences for banks and the entire financial system. For gold producers and exploration companies, this means further momentum. While Barrick Mining is a core investment, it is also suffering from home-grown problems. AJN Resources is working on the comeback story of the year in the commodities sector. The valuation is still favorable, and exciting news is on the horizon. In the defense sector, consolidation could already be over. The escalating conflict between Israel and Iran will likely drive the shares of RENK, Rheinmetall, and others. Analysts see potential for RENK to reach a new all-time high, and the Company recently reported an order from outside Europe.
Read